Optimizing adjuvant endocrine therapy in premenopausal patients with HER2-positive, hormone receptor-positive breast cancer.

Valenza, C., Partridge, A. H., & Regan, M. M. (2026). Optimizing adjuvant endocrine therapy in premenopausal patients with HER2-positive, hormone receptor-positive breast cancer.. Breast (Edinburgh, Scotland), 85, 104696.